Danmark - dansk - SEGES Landbrug & Fødevarer

adama northern europe b.v. - folpet - suspensionskoncentrat - 500 g/l folpet

Danmark - dansk - SEGES Landbrug & Fødevarer

adama northern europe b.v. - folpet, epoxiconazol - flydende middel - 375 g/l folpet; 50 g/l epoxiconazol

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

huvepharma nv - tilmicosinphosphat - premix - 100 g/kg - svin

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

huvepharma nv - tilmicosinphosphat - premix - 200 g/kg - svin

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

huvepharma nv - tilmicosinphosphat - premix - 40 g/kg - svin

Den Europæiske Union - dansk - EMA (European Medicines Agency)

merck sharp & dohme b.v. - peginterferon alfa-2b - hepatitis c kronisk - immunostimulants, - adults (tritherapy)pegintron in combination with ribavirin and boceprevir (tritherapy) is indicated for the treatment of chronic-hepatitis-c (chc) genotype-1 infection in adult patients (18 years of age and older) with compensated liver disease who are previously untreated or who have failed previous therapy. der henvises til ribavirin og boceprevir produktresuméer (smpcs), når pegintron skal anvendes i kombination med disse lægemidler. adults (bitherapy and monotherapy)pegintron is indicated for the treatment of adult patients (18 years of age and older) with chc who are positive for hepatitis-c-virus rna (hcv-rna), including patients with compensated cirrhosis and / or co-infected with clinically stable hiv. pegintron i kombination med ribavirin (bitherapy) er indiceret til behandling af chc-infektion hos voksne patienter, der er tidligere ubehandlet, herunder patienter med klinisk stabilt hiv co-infektion, og hos voksne patienter, der har undladt tidligere behandling med interferon-alfa (pegyleret eller non-pegyleret) og ribavirin kombination terapi eller alfa-interferon-monoterapi. interferon monoterapi, herunder pegintron, er indikeret primært i tilfælde af intolerance eller kontraindikation for ribavirin. der henvises til ribavirin spc, når pegintron er at blive brugt i kombination med ribavirin. paediatric population (bitherapy)pegintron is indicated in a combination regimen with ribavirin for the treatment of children three years of age and older and adolescents who have chc, previously untreated, without liver decompensation, and who are positive for hcv-rna. når det besluttes ikke at udsætte behandlingen, indtil voksenalderen, det er vigtigt at overveje, at kombinationen af terapi-induceret vækst-hæmning, der kan være uoprettelige hos nogle patienter. beslutningen om at behandle en sag-for-sag. der henvises til ribavirin produktresumeet for kapsler eller oral opløsning, når pegintron er at blive brugt i kombination med ribavirin.

Danmark - dansk - SEGES Landbrug & Fødevarer

basf a/s - metconazol - emulsionskoncentrat - 90 g/l metconazol

Den Europæiske Union - dansk - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - immunosuppressiva - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.

Danmark - dansk - SEGES Landbrug & Fødevarer

globachem nv - metconazol - emulsionskoncentrat - 90 g/l metconazol

Den Europæiske Union - dansk - EMA (European Medicines Agency)

photonamic gmbh & co. kg - 5-aminolevulinsyrehydrochlorid - gliom - antineoplastiske midler - gliolan er indiceret hos voksne patienter til visualisering af malignt væv under operationen for malignt gliom (verdenssundhedsorganisation iii og iv).